R01 AG043375/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	5
2003	3
2004	6
2005	5
2006	6
2007	4
2008	13
2009	14
2010	19
2011	18
2012	15
2013	19
2014	24
2015	19
2016	22
2017	16
2018	9
2019	10
2020	6
2021	8
2022	3
2023	1
2024	1

1

Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, Propson NE, Xu Y, Jankowsky JL, Liu Z, Lee VM, Trojanowski JQ, Ginsberg SD, Butovsky O, Zheng H, Cao W. Roy ER, et al. J Clin Invest. 2020 Apr 1;130(4):1912-1930. doi: 10.1172/JCI133737. J Clin Invest. 2020. PMID: 31917687 Free PMC article.

2

Multi-Infarct Dementia: A Historical Perspective.

McKay E, Counts SE. McKay E, et al. Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):160-171. doi: 10.1159/000470836. eCollection 2017 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2017. PMID: 28626470 Free PMC article. Review.

3

The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Salehi A, Ashford JW, Mufson EJ. Salehi A, et al. Curr Alzheimer Res. 2016;13(1):2-6. doi: 10.2174/1567205012999151021102914. Curr Alzheimer Res. 2016. PMID: 26487155 Free PMC article. No abstract available.

4

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Goldman JG, Aggarwal NT, Schroeder CD. Goldman JG, et al. Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30. Neurodegener Dis Manag. 2015. PMID: 26517759 Free PMC article. Review.

5

Hippocampal plasticity during the progression of Alzheimer's disease.

Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, Ginsberg SD, Ikonomovic MD, Scheff SW, Binder LI. Mufson EJ, et al. Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12. Neuroscience. 2015. PMID: 25772787 Free PMC article. Review.

6

Tau as a therapeutic target in neurodegenerative disease.

Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI. Himmelstein DS, et al. Pharmacol Ther. 2012 Oct;136(1):8-22. doi: 10.1016/j.pharmthera.2012.07.001. Epub 2012 Jul 10. Pharmacol Ther. 2012. PMID: 22790092 Free PMC article. Review.

7

Galanin in Alzheimer disease.

Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Counts SE, et al. Mol Interv. 2003 May;3(3):137-56. doi: 10.1124/mi.3.3.137. Mol Interv. 2003. PMID: 14993421 Review.

8

Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD. Mufson EJ, et al. Behav Brain Res. 2016 Sep 15;311:54-69. doi: 10.1016/j.bbr.2016.05.030. Epub 2016 May 13. Behav Brain Res. 2016. PMID: 27185734 Free PMC article. Review.

9

Expression profiling in the aging brain: a perspective.

Galvin JE, Ginsberg SD. Galvin JE, et al. Ageing Res Rev. 2005 Nov;4(4):529-47. doi: 10.1016/j.arr.2005.06.009. Epub 2005 Oct 24. Ageing Res Rev. 2005. PMID: 16249125 Review.

10

Biomarkers for the Early Detection and Progression of Alzheimer's Disease.

Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ. Counts SE, et al. Neurotherapeutics. 2017 Jan;14(1):35-53. doi: 10.1007/s13311-016-0481-z. Neurotherapeutics. 2017. PMID: 27738903 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year